ArticleClinical and experimental medicine2023

CD44v6 downregulation as a prognostic factor for distant recurrence in resected stage I lung adenocarcinomas.

Chihiro Yoshida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.